Stroke in Heart Failure: Atrial Fibrillation Revisited?

Journal of Stroke and Cerebrovascular Diseases

Volumn 19, Issue 1, 2010, Pages 1-2

  Pullicino, Patrick ^a   Homma, Shunichi ^b  

^a UNIVERSITY OF KENT   (United Kingdom)

^b Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STROKE;

ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; HEART FAILURE; HEMORRHAGE; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; STROKE; TREATMENT OUTCOME; WARFARIN;

EID: 72649083051     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2009.09.002     Document Type: Editorial

References (13)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Int Med (1994) 1449-1457
2. Hart R.G., Benavente O., McBride R., et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Int Med 131 (1999) 492-501
3. Gage B.F., Van Walraven C., Pearce L., et al. Selecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirin. Circulation 110 (2004) 2287-2292
4. Pullicino P., Homma S., Thompson J.L., et al. Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm. Cerebrovasc Dis 26 (2008) 322-327
5. Massie B.M., Collins J.F., Ammon S.E., et al. WATCH Trial Investigators. The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial. Circulation 119 (2009) 1616-1624
6. Al-Khadra A.S., Salem D.N., Rand W.M., et al. Warfarin anticoagulation and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 31 (1998) 749-753
7. Freudenberger R.S., Hellkamp A.S., Halperin J.L., et al. SCD-HeFT Investigators. Risk factors for thromboembolism in the SCD-Heft Study. Circulation 115 (2007) 2637-2641
8. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
9. Witt B.J., Brown Jr. R.D., Jacobsen S.J., et al. Ischemic stroke after heart failure: A community-based study. Am Heart J 152 (2006) 102-109
10. Raphael C.E., Whinnet Z.I., Davies J.E., et al. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 95 (2009) 56-62
11. Pullicino P.M., McClure L.A., Wadley V.G., et al. Blood pressure and stroke in heart failure in the REGARDS Study. Stroke 40 (2009) 3706-3710
12. Petty G.W., Brown Jr. R.D., Whisnant J.P., et al. Survival and recurrence after first cerebral infarction: A population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 50 (1998) 208-216
13. Sacco R.L., Shi T., Zamanillo M.C., et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: The Northern Manhattan Stroke Study. Neurology 44 (1994) 626-634